Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio


French drugmaker Sanofi SA said on Tuesday it expects to get approval for the potential Covid-19 vaccine it is developing with Britain's GlaxoSmithKline Plc by the first half of next year, faster than previously anticipated.
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.
"We are being guided by our dialogue with regulatory authorities," Sanofi research chief John Reed told reporters, when asked about the accelerated time frame. Read More

Comments

Popular posts from this blog

Instagram adds group video call, new camera effects to app: How they work

3 Investment Strategies for Financial Independence!

G7 pledges 870 mn Covid vaccine doses, half to be delivered by 2021-end